[1]
|
[1]IMAI T, HIESHIMA K, HASKELL C, et al.Identification and molecular charact-erization of fractalkine receptor CX3CR1, which mediates both leukocyte mi-gration and adhesion[J].Bioscience Biotechnology&Biochemistry, 1997, 91 (4) :521-530.
|
[2]
|
[2]KOBAYASHI T, OKAMOTO S, IWAKAMI Y, et al.Exclusive increase of CX3C-R1+CD28-CD4+T cells in inflammatory bowel disease and their recruitment as intraepithelial lymphocytes[J].Inflammatory Bowel Diseases, 2007, 13 (7) :837-846.
|
[3]
|
[3]SORIANO S G, AMARAVADI L S, WANG Y F, et al.Mice deficient in fractalkine are less susceptible to cerebral ischemia-reperfusion injury[J].Journal of N-euroimmunology, 2002, 125 (1-2) :59-65.
|
[4]
|
[4]OWLASIUK P, ZAJKOWSKA J M, PIETRUCZUK M, et al.Fractalkine structure, func-tions and biological activity[J].Polski Merkuriusz Lekarski Organ Polskiego Towarzystwa Lekarskiego, 2009, 26 (153) :253-257.
|
[5]
|
[5]KOZIOLEK M J, MLLER G A, ZAPF A, et al.Role of CX3C-chemokine CX3-CL/fractalkine expression in a model of slowly progressive renal failure[J].Nephrology Dialysis Transplantation, 2010, 25 (3) :684-698.
|
[6]
|
[6]MC DERMOTT D H, COLLA J S, KLEEBERGER C A, et al.Genetic polymorphism in CX3CR1 and risk of HIV disease[J].Science, 2000, 290 (5499) :2031.
|
[7]
|
[7]MAHO A, BENSIMON A, VASSART G, et al.Mapping of the CCXCR1, CX3C-R1, CCBP2 and CCR9 genes to the CCR cluster within the 3p21.3 region of the human genome[J].Cytogenetics&Cell Genetics, 2000, 87 (3-4) :265-268.
|
[8]甄瑞峰, 唐灵.FKN与疾病的研究进展[J].医学综述, 2009, 15 (20) :3061-3064.
|
[9]
|
[9]ZHENDONG L I, SHIJIAN LUO, FENG WANG, et al.An association study betwe-en polymorphisms of the fractalkine receptor gene, CX3CR1, and cerebral in-farction in the Han Chinese population[J].Journal of the Neurological Sciences, 2012, 320 (1-2) :12-15.
|
[10]刘明旭, 王福生, 洪卫国, 等.中国汉族和维吾尔族艾滋病病毒感染者与未感染人群中CX3CR1基因多态性的分布[J].中华流行病学杂志, 2003, 24 (7) :595-598.
|
[11]
|
[11]APOSTOLAKIS S, BARITAKI S, KOCHIADAKIS G E, et al.Effects of polymorphi-sms in chemokine ligands and receptors on susceptibility to co-ronary artery disease[J].Thrombosis Research, 2007, 119 (1) :63-71.
|
[12]
|
[12]ZERBIB J, PUCHE N, RICHARD F, et al.No association between the T280M p-olymorphism of the CX3CR1 gene and exudative AMD[J].Experimental Eye Research, 2011, 93 (4) :382-386.
|
[13]
|
[13]STOJKOVI L, DJURI T, STANKOVI A, et al.The association of V249I and T280M fractalkine receptor haplotypes with disease course of multiple sclero-sis[J].Journal of Neuroimmunology, 2012, 245 (1-2) :87-92.
|
[14]
|
[14]SINGH N, SINHA N, KUMAR S, et al.Suraks-ha Agrawal Polymorphism in c-hemokine receptor genes and risk of acute myocardial infarction in North In-dian population[J].Molecular Biology Reports, 2012, 39 (3) :2753-2759.
|
[15]
|
[15]NORATA G D, GARLASCHELLI K, ONGARI M, et al.Effects of fractalkine recept-or variants on common carotid artery intima-media thickness[J].Stroke, 2006, 37 (6) :1558-1561.
|
[16]
|
[16]FAURE S, MEYER L, COSTAGLIOLA D, et al.Rapid progression to AIDS in HIV+individuals with a structural variant of the chemokine receptor CX3CR1[J].Science, 2000, 287 (5461) :2247-2277.
|
[17]叶峻杰, 王福生, 彭林, 等.云南傣族景颇族人群中与艾滋病相关的CX3CR1基因多态性分布[J].中国优生与遗传杂志, 2004, 12 (3) :16-17.
|
[18]
|
[18]WONG BWC, WONG D, MCMANUS BM.Characterization of fractalkine (C-X3CL1) and CX3CR1 in human coronary arteries with native atherosclerosis, diabetes mellitus, and transplant vascular disease[J].Cardiovascular Pathology, 2002, 11 (6) :332-338.
|
[19]
|
[19]YADAV A K, KUMAR V, JHA V.Association of chemokine receptor CX3C-R1 V249I and T280M polymorphisms with chronic kidney disease[J].Indian Journal of Nephrology, 2016, 26 (4) :275-279.
|
[20]
|
[20]BABAKURBAN S T, ERBEK S S, TERZI Y K, et al.Fractalkine receptor polymo-rphism and chronic to-nsillitis[J].European Archives of Oto-Rhino-Laryngology, 2014, 271 (7) :2045-2048.
|
[21]彭旭, 张智博, 唐璐, 等.缺血性脑血管病患者趋化因子受体CX3C-R1基因T280M多态性的研究[J].临床神经病学杂志, 2008, 21 (5) :329-332.
|
[22]
|
[22]MCDERMOTT D H, HALCOX J P, SCHENKE W H, et al.Association between po-lymorphism in the chemokine receptor CX3CR1 and coronary vascular endo-thelial dysfunction and atherosclerosis[J].Circulation Research, 2001, 89 (5) :401-407.
|
[23]龙莉, 杨榆玲, 瞿秋, 等.血管紧张素原基因M235T多态性在云南彝族人群中的分布[J].昆明医科大学学报, 2012, 33 (11) :4-7.
|
[24]龙莉, 莫艳萍, 何永蜀, 等.血管紧张素转换酶基因I/D多态性在云南省彝族人群中的分布[J].昆明医科大学学报, 2009, 30 (7) :46-49.
|
[25]杨榆玲, 龙莉, 瞿秋, 等.血管紧张素Ⅱ1型受体A1166C多态性在云南彝族人群中的分布[J].昆明医科大学学报, 2012, 33 (5) :43-46.
|
[26]陈国文, 尤开, 龙莉, 等.MCP-1G-2518A多态性在云南彝族人群中的分布[J].昆明医科大学学报, 2016, 37 (2) :5-9.
|
[27] 尤开, 陈国文, 刘珊灵, 等.CCR2b基因190G/A多态性在云南省彝族人群中的分布[J].昆明医科大学报, 2016, 37 (1B) :565-568.
|